263 related articles for article (PubMed ID: 11685455)
21. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Cheng TY; Lin JT; Chen LT; Shun CT; Wang HP; Lin MT; Wang TE; Cheng AL; Wu MS
J Clin Oncol; 2006 Jul; 24(21):3483-9. PubMed ID: 16849765
[TBL] [Abstract][Full Text] [Related]
22. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease.
Amundsen SS; Naluai AT; Ascher H; Ek J; Gudjónsdóttir AH; Wahlström J; Lie BA; Sollid LM
Tissue Antigens; 2004 Nov; 64(5):593-9. PubMed ID: 15496203
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.
Tezuka K; Tsuji T; Hirano D; Tamatani T; Sakamaki K; Kobayashi Y; Kamada M
Biochem Biophys Res Commun; 2000 Sep; 276(1):335-45. PubMed ID: 11006126
[TBL] [Abstract][Full Text] [Related]
24. No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.
Wiencke K; Boberg KM; Donaldson P; Harbo H; Ling V; Schrumpf E; Spurkland A
Scand J Gastroenterol; 2006 May; 41(5):586-91. PubMed ID: 16638702
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease.
Ban Y; Davies TF; Greenberg DA; Kissin A; Marder B; Murphy B; Concepcion ES; Villanueva RB; Barbesino G; Ling V; Tomer Y
Genes Immun; 2003 Dec; 4(8):586-93. PubMed ID: 14647199
[TBL] [Abstract][Full Text] [Related]
26. CTLA-4 and CD28: similar proteins, neighbouring genes.
Balzano C; Buonavista N; Rouvier E; Golstein P
Int J Cancer Suppl; 1992; 7():28-32. PubMed ID: 1330947
[TBL] [Abstract][Full Text] [Related]
27. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
[TBL] [Abstract][Full Text] [Related]
28. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.
Teutsch SM; Booth DR; Bennetts BH; Heard RN; Stewart GJ
J Neuroimmunol; 2004 Mar; 148(1-2):218-30. PubMed ID: 14975605
[TBL] [Abstract][Full Text] [Related]
29. Contribution of PTPN22, CD28, CTLA-4 and ZAP-70 variants to the risk of type 1 diabetes in Tunisians.
Zouidi F; Stayoussef M; Bouzid D; Fourati H; Abida O; Ayed MB; Kammoun T; Hachicha M; Penha-Gonçalves C; Masmoudi H
Gene; 2014 Jan; 533(1):420-6. PubMed ID: 24103478
[TBL] [Abstract][Full Text] [Related]
30. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
31. A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes.
Wood JP; Pani MA; Bieda K; Meyer G; Usadel KH; Badenhoop K
Eur J Immunogenet; 2002 Aug; 29(4):347-9. PubMed ID: 12121283
[TBL] [Abstract][Full Text] [Related]
32. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population.
McCormack RM; Maxwell AP; Carson D; Patterson CC; Bingham A; Savage DA
Genes Immun; 2001 Jun; 2(4):233-5. PubMed ID: 11477480
[TBL] [Abstract][Full Text] [Related]
33. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population.
Brophy K; Ryan AW; Thornton JM; Abuzakouk M; Fitzgerald AP; McLoughlin RM; O'morain C; Kennedy NP; Stevens FM; Feighery C; Kelleher D; McManus R
Genes Immun; 2006 Jan; 7(1):19-26. PubMed ID: 16237465
[TBL] [Abstract][Full Text] [Related]
34. Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups.
Guzman VB; Morgun A; Shulzhenko N; Mine KL; Gonçalves-Primo A; Musatti CC; Gerbase-Delima M
Hum Immunol; 2005 Jul; 66(7):773-6. PubMed ID: 16112024
[TBL] [Abstract][Full Text] [Related]
35. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.
Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S
Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in the 2q33 and 3q21 chromosome regions including T-cell coreceptor and ligand genes may influence susceptibility to pemphigus foliaceus.
Dalla-Costa R; Pincerati MR; Beltrame MH; Malheiros D; Petzl-Erler ML
Hum Immunol; 2010 Aug; 71(8):809-17. PubMed ID: 20433886
[TBL] [Abstract][Full Text] [Related]
37. Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma.
Kämmerer PW; Toyoshima T; Schöder F; Kämmerer P; Kuhr K; Brieger J; Al-Nawas B
Oral Oncol; 2010 Jul; 46(7):543-8. PubMed ID: 20435510
[TBL] [Abstract][Full Text] [Related]
38. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
[TBL] [Abstract][Full Text] [Related]
39. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
Ban Y; Taniyama M; Tozaki T; Yanagawa T; Yamada S; Maruyama T; Kasuga A; Tomita M; Ban Y
Autoimmunity; 2001; 34(1):39-43. PubMed ID: 11681491
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Agarwal K; Czaja AJ; Jones DE; Donaldson PT
Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
